Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://keithyjqi916441.smblogsites.com/40654955/tirzepatide-a-new-frontier-in-diabetes-treatment